Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2026-04-22 @ 4:03 PM
Study NCT ID:
NCT05049850
Status:
TERMINATED
Last Update Posted:
2025-10-21
First Post:
2021-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation
Sponsor:
Hansa Biopharma AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
18-HMedIdeS-16
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None